Skip to content
Use case 140

Surgical Robot Control Systems

A deployment concept for hospitals, surgical robot manufacturers, clinicians and medical device regulators.

Proposed deployment · Compatibility assessment required
Healthcare and Life Sciences

Why this environment matters

The platform for surgical robot control systems translates surgeon inputs into precise instrument movement and video-assisted procedures. The operational risk is specific: software compromise, latency manipulation or unauthorised maintenance access could affect movement during surgery. NØNOS could provide a smaller, memory-safe base for dividing that workflow into signed, least-privilege components and restoring it from a known state after each sensitive session or incident.

The security challenge

The practical concern is that software compromise, latency manipulation or unauthorised maintenance access could affect movement during surgery. Healthcare systems process deeply sensitive data while supporting time-critical clinical decisions. Security must improve trust without delaying care or obscuring the human responsibility for treatment. The attack surface may include remote support, software updates, removable media, third-party libraries, public input or misused operator credentials. The security design therefore needs containment as well as prevention.

How the capsule model could help

The proposed deployment pattern is to separate surgeon controls, vision, motion planning, logging and service functions with strict hardware capabilities and attestation. NØNOS would use patient-context capabilities and signed clinical software as the trust foundation, then apply isolated medical file parsers and minimal sensitive persistence around higher-risk functions. Logs or proofs could record which approved capsule performed a privileged action without retaining unnecessary user data.

Separate address spaces and capability checks can limit cross-process reach. They cannot stop harmful use of legitimate permissions, prove AI decisions correct or substitute for domain-specific safety controls.

Deployment requirements

Clinical deployment would require medical-device validation, patient-safety risk management, privacy review, human factors testing and integration with existing approved workflows. Security controls must never obstruct emergency care.

Current public-beta limitations, hardware support and application availability must be assessed before any pilot. Neither this use case nor an industry source establishes NONOS certification or a current customer deployment.

Who could buy or integrate it?

  • Surgical robot manufacturers researching controller architectures
  • Medical robotics engineering contractors integrating control software
  • Hospital robotics programmes purchasing systems with vendor-approved integrations

Industry examples: Intuitive Surgical, CMR Surgical. Organisations shown illustrate the industry. No NONOS customer, partner or endorsement relationship is implied.

Market opportunity

Market benchmarks and device scenarios.

Published industry benchmark
US$14.1 billion

Surgical robots

Global · 2025 · annual market estimate

Surgical robotic systems, accessories and services across procedures and care settings.

Modelled global devices
1K–24K

Candidate OS endpoints

Hypothetical planning range · 2025

Low confidence: planning assumptions. Hardware compatibility, procurement and adoption have not been validated.

Illustrative annual licensing
$200K–$24M

USD / year at full model coverage

Device scenario × assumed US$200–$1000 per device / year.

Not a revenue forecast, announced price or measured serviceable market.

Device calculation

Hypothetical global planning range, 2025 scenario: assume 1,000–6,000 hospitals performing robot-assisted surgery × 1–4 candidate OS endpoints per site/asset = 1,000–24,000 endpoints. Counting unit: surgeon/robot supervisory control computers; console count must be validated. Site and asset counts, and devices per site, are planning assumptions. The installed base has not been measured. Coverage is limited to the defined equipped subset; includes all candidate endpoints within that assumed subset. Hardware eligibility, certification, adoption and achievable NØNOS share are unverified; overlaps other cases.

Surgical Robots Market Size & Share Report, 2026-2033 ↗

Market context only; separate from device and site population estimates. Original monetary-market scope and geography are preserved in benchmark. This source does not establish the assumed worldwide site count or endpoint density.

How to interpret the figures

Adjacent or broader commercial market benchmark; not the NØNOS OS market, licensable-device count or revenue forecast.

Modelled candidate endpoints multiplied by an assumed annual USD price per endpoint. Pricing is a planning assumption, not a vendor quote. This illustrates the full scenario range, not revenue or total addressable market. It excludes adoption timing, procurement, certification, support costs, channel economics and achievable market share. Use cases can overlap, so their totals do not represent unique devices.

Research from 2026. Publisher estimates have not been independently audited.

Read the full methodology

Explore NONOS

Choose your
NONOS experience.

Discover the platform for your organisation or explore the software.

You can reopen this chooser from the footer at any time.